Sowell Financial Services LLC Intercept Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$19.33 - $37.75 $6,069 - $11,853	-314 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$24.48 - $42.47 $40,783 - $70,755	-1,666 Reduced 84.14%	314 $8,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $3,009 - $4,114	-77 Reduced 3.74%	1,980 $82,000
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $71,170 - $140,268	1,524 Added 285.93%	2,057 $99,000
Q1 2020 May 12, 2020	SELL	$48.35 - $118.68 $5,898 - $14,478	-122 Reduced 18.63%	533 $34,000
Q4 2019 Feb 07, 2020	BUY	$57.36 - $124.1 $30,974 - $67,014	540 Added 469.57%	655 $81,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $6,749 - $9,252	115 New	115 $8,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.